Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Astrana Health ( (ASTH) ) is now available.
On July 1, 2025, Astrana Health completed its acquisition of Prospect Health for $708 million, a reduction from the initially announced $745 million. This acquisition is expected to enhance Astrana’s capabilities in providing high-quality care, with Prospect Health contributing approximately $1.2 billion in revenue and $81 million in adjusted EBITDA annually. The acquisition is anticipated to create synergies of $12 to $15 million over the next 12 to 18 months, and Astrana has updated its full-year 2025 guidance to reflect the transaction’s impact.
The most recent analyst rating on (ASTH) stock is a Buy with a $60.00 price target. To see the full list of analyst forecasts on Astrana Health stock, see the ASTH Stock Forecast page.
Spark’s Take on ASTH Stock
According to Spark, TipRanks’ AI Analyst, ASTH is a Outperform.
Astrana Health’s overall stock score is influenced primarily by its strong financial performance and positive earnings call, which highlight robust revenue growth and strategic expansion efforts. However, technical indicators and high valuation present challenges, along with potential risks from medical cost trends and margin pressures. Corporate events provide some support to the score by enhancing governance and leadership.
To see Spark’s full report on ASTH stock, click here.
More about Astrana Health
Astrana Health is a physician-centric, AI-powered healthcare company that focuses on delivering high-quality, patient-centered care. It combines scalable care delivery infrastructure, proprietary technology, and aligned provider networks to enable proactive, preventive care at scale, supporting over 20,000 providers and 1.6 million patients through its affiliated networks and clinics.
Average Trading Volume: 282,404
Technical Sentiment Signal: Sell
Current Market Cap: $1.25B
Learn more about ASTH stock on TipRanks’ Stock Analysis page.